The Prosemble team recently attended the Pioneer Group Summer Graduate Soirée, an event celebrating innovation, networking, and collaboration across the life sciences and technology sectors. During the event, team members met with: Tiffany Thorn, Founder & CEO of...

We’re delighted to announce a significant expansion of the Prosemble team as we continue to grow our capabilities across both AI and life sciences. Please join us in welcoming our newest colleagues and consultants: Tamara Veres – AI/Bioinformatics Specialist (Dry Lab)...

Prosemble is pleased to announce that its Chief Financial Officer and Chief Operating Officer, Inna Zhuranskaya, attended the World Finance Forum – London Autumn 2025 this week. During the event, Ms Zhuranskaya met with Bili Eseanobi, Associate Director of Commercial...

Inna Zhuranskaya recently attended the Twin Path Portfolio Day, an event bringing together leaders and innovators from across technology, healthcare, and venture capital. During the event, Inna met with James Rosenthal, Director, Global Strategic Initiatives, Google...

Prosemble is pleased to announce the commencement of the immunogenicity phase of its mouse trials, conducted in partnership with TransCure BioServices, following the successful completion of the safety stage. This new phase will assess immune responses in CD34+...

We are proud to announce that Iryna Peretiazhko, currently completing her PhD at the Francis Crick Institute and Imperial College London under the supervision of Prof. Peter Rosenthal (Crick) and Dr Beeby (Imperial College), has had her article published in Nature —...